Holdings of Foresite Capital Management VI LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 15 in 1 countries
- Top ten
- 92.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CG oncology Inc | 2,221,474 | 150.3M $ | |
| 2 | Alumis Inc | 4,247,670 | 93.6M $ | |
| 3 | CENTESSA PHARMACEUTICALS PLC | 1,364,019 | 54.2M $ | |
| 4 | Corvus Pharmaceuticals Inc | 1,831,233 | 26.8M $ | |
| 5 | Denali Therapeutics Inc | 1,209,971 | 23.2M $ | |
| 6 | Agios Pharmaceuticals Inc | 525,000 | 17.8M $ | |
| 7 | Verastem Inc | 3,146,631 | 16.7M $ | |
| 8 | Kymera Therapeutics Inc | 146,332 | 12.2M $ | |
| 9 | Minerva Neurosciences Inc | 1,986,600 | 12M $ | |
| 10 | Celldex Therapeutics Inc | 315,913 | 10M $ | |
| 11 | AtaiBeckley Inc | 2,750,000 | 9.7M $ | |
| 12 | Hinge Health Inc | 220,400 | 8.5M $ | |
| 13 | Crinetics Pharmaceuticals Inc | 212,010 | 7.7M $ | |
| 14 | OnKure Therapeutics Inc | 1,445,783 | 6M $ | |
| 15 | JADE BIOSCIENCES INC | 320,000 | 4.5M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 15 | 453.2M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Foresite Capital Management VI LLC". https://titelia.com/en/funds/US13F2013341